Related Experiment Video

Updated: Aug 18, 2026

In Vitro Assay to Study Tumor-macrophage Interaction
08:36

In Vitro Assay to Study Tumor-macrophage Interaction

Published on: August 1, 2019

Macrophage fusion: are somatic and cancer cells possible partners?

Agnès Vignery1

  • 1Yale University School of Medicine, Dept of Orthopaedics and Rehabilitation, TMP534, 310 Cedar Street, New Haven CT 06510, USA. agnes.vignery@yale.edu

Trends in Cell Biology
|April 9, 2005
PubMed

Insights

Macrophages fuse via a novel mechanism involving the macrophage fusion receptor (MFR) and CD47, enabling tissue repair or metastasis. This discovery sheds light on macrophage roles in disease and healing.

Area of Science:

  • Cell Biology
  • Immunology
  • Tissue Engineering

Background:

  • Macrophages are vital immune cells found in all tissues.
  • Macrophage fusion is critical for forming osteoclasts (bone resorption) and giant cells (inflammation).
  • The precise molecular mechanisms governing macrophage fusion remain largely unknown.

Purpose of the Study:

  • To investigate the molecular mechanisms underlying macrophage homotypic fusion.
  • To identify potential receptors and ligands involved in macrophage self-recognition and fusion.
  • To explore the implications of macrophage fusion in physiological and pathological processes.

Main Methods:

  • The study likely involved in vitro assays to observe macrophage fusion.
  • Investigated the role of the macrophage fusion receptor (MFR) and its ligand CD47 in mediating fusion.
  • Utilized techniques to assess cell-cell recognition and membrane dynamics during fusion.

Main Results:

  • Identified the macrophage fusion receptor (MFR) and its ligand CD47 as potential mediators of macrophage homotypic fusion.
  • Demonstrated that MFR/CD47 interaction may facilitate 'self' recognition, a prerequisite for fusion.
  • Proposed a novel mechanism for macrophage fusion with potential implications beyond homotypic interactions.

Conclusions:

  • Macrophage fusion is mediated by a specific receptor-ligand interaction (MFR/CD47).
  • This mechanism allows macrophages to recognize each other as 'self' before fusion.
  • Macrophage fusion plays a dual role, contributing to both tissue repair and disease processes like metastasis.

More Related Videos

A Macrophage-Tumor Spheroid Co-Invasion Assay09:01

A Macrophage-Tumor Spheroid Co-Invasion Assay

Published on: January 24, 2025

Time-Lapse 2D Imaging of Phagocytic Activity in M1 Macrophage-4T1 Mouse Mammary Carcinoma Cells in Co-cultures10:23

Time-Lapse 2D Imaging of Phagocytic Activity in M1 Macrophage-4T1 Mouse Mammary Carcinoma Cells in Co-cultures

Published on: December 14, 2019

Related Concept Videos

Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Immune Surveillance by NK Cells and Phagocytes01:25

Immune Surveillance by NK Cells and Phagocytes

Immune surveillance is an integral part of the innate immune system, involving the continuous monitoring of peripheral tissues to detect and respond to pathogens, infected cells, or cancerous cells. This surveillance is conducted primarily by natural killer (NK) cells and phagocytes, which employ distinct but complementary mechanisms to identify and eliminate threats.
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...